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ABSTRACT
Current operational procedures for shuttle crewmembers includes
the ingestion of a fluid countermeasure approximately 2 hours
before reentry into the earth's gravitational field. The ingestion
of the fluid countermeasure is thought to restore plasma volume and
improve orthostatic responses upon reentry. The present
countermeasure consists of ingesting salt tablets and water to
achieve an isotonic solution. It has yet to be determined whether
this is the optimal drink to restore orthostatic tolerance. It is
also not known whether the drink solution is effective in
increasing plasma volume. The purpose of this study was evaluate
the effectiveness of drink solutions of different osmolarity on
restoring plasma volume and orthostatic responses. Six men (age
= 31 ± 3.5 yrs, weight = 80.2 _ 4.7 kg, height = 179.8 ± 2.6 cm)
were tested after giving informed consent and a medical screening.
Each subject participated in four conditions. In all four
conditions lower body negative pressure (LBNP) was used to test
orthostatic responses. In the first condition, orthostatic
responses were tested after no change in hydration state of the
subject (euhydrated). In the second condition, the subject was
dehydrated with lasix administration (20 mg IV). This was done to
simulate the loss of plasma volume during spaceflight. In a third
condition, orthostatic responses were tested following dehydration
and rehydration with an isotonic countermeasure ( 1 liter of .9%
saline). In the final condition, a hyperosmotic drink solution (i
liter of 1.07% saline) was given after lasix dehydration. Plasma
volume, leg circumference, plasma osmolarity, forearm blood flow,
heart rate, stroke volume, blood pressure, thoracic fluid index,
and cardiac dimensions (echocardiography) were measured during
rest, LBNP exposure, and recovery. Subjects lost approximately 12%
of the initial plasma volume (420 ml) as a result of dehydration
with lasix. Rehydration with the isotonic solution partially
restored plasma volume, whereas the hypertonic drink solution fully
restored plasma volume back to the euhydrated level. Thoracic fluid
index (TFI) increased during LBNP in all conditions. However, the
starting level of TFI were different, reflecting the differences
in plasma volume. This suggests that there was a greater central
blood volume during the euhydrated and hypertonic conditions than
in the dehydrated and isotonic conditions. Even though there were
differences in plasma volume and TFI, there were few differences
in any other responses measured. Heart rate was slightly elevated
during the dehydrated condition relative to the other three
conditions. Stroke volume, systolic and diastolic blood pressure,
forearm blood flow, and leg circumference were not different
between conditions. The 12% reduction in plasma volume observed in
this study was not sufficient to produce profound differences in
the cardiovascular responses to orthostatic stress. This suggests
that other mechanisms might be operational in producing the
orthostatic intolerance following short duration space flight.
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INTRODUCTION
Orthostatic hypotension has been commonly reported after space
flight by crewmembers both during reentry and upon egress from a
spacecraft. The decrease in blood pressure could have severe
ramifications on the ability of the crew to control the spacecraft
during reentry and any emergency egress that might occur.
Orthostatic intolerance after short duration space flight (5-14
days) is thought to be a result of a reduction in plasma volume.
Plasma volume decreases during spaceflight as a result of a
negative water balance. The decrease in plasma volume has been
reported to be between 8 and 15% (8). In microgravity, there is a
redistribution of fluids from the lower body to the head and upper
body. Originally this was thought to result in a suppression of
antidiuretic hormone and a potentiated diuresis (7). Recent
studies have suggested that atrial natriuretic factor (ANF) is
involved in the control of plasma volume during volume expansion
(9,10). It is possible that ANF is involved in plasma volume
regulation during space flight.
Crew members are well suited to a microgravity environment.
However, upon return to a gravitational environment they are
hypovolemic relative to preflight and thus more prone to
orthostatic intolerance. A study by Bungo and Charles(l) has
indicated that fluid ingestion prior to reentry minimizes the
impairment of orthostatic responses following spaceflight. They
attribute the improvement in orthostatic responses in those
crewmembers that ingested a fluid countermeasure to a restoration
of plasma volume as a direct result of the ingestion of the
solution. No controlled measurements of plasma volume with and
without the countermeasure have ever been made.
The present countermeasure consists of ingesting salt tablets
and eight ounces of water approximately 2 hours before reentry.
This is thought to result in an isotonic solution (.9% saline).
A recent study by Bungo et al. (2) has looked at the ingestion of
drinks of varying osmolarity and composition on plasma volume.
They found that a hypertonic drink solution was more effective in
increasing and maintaining plasma volume (4 hours).
To date, no studies have looked at the relationship between
plasma volume and LBNP tolerance in a controlled study. The
purpose of this study was to evaluate the effectiveness of drink
solutions of varying osmolarity on restoring plasma volume and
orthostatic responses.
HISTORICAL BACKGROUND
For a detailed historical background, please see 1988 Summer
Faculty Fellowship Report (4).
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METHODS
Six volunteers were recruited for the study by Krug
International. All subjects were medically screened and given a
detailed explanation of the study. Informed consent was obtained
from all subjects before participating in the study. The study
was approved by the JSC IRB. Each subject participated in four
conditions: i) LBNP control - euhydrated (EUH), 2) LBNP following
lasix dehydration (DEH), 3) LBNP following lasix dehydration (20
mg IV) and rehydration (ISO) with an isotonic drink solution (I
liter of a .9% saline solution), and 4) LBNP following dehydration
with lasix and rehydration (HYPER) with a hypertonic drink (! liter
of a 1.07% saline solution). Control LBNP tests were administered
to each subject until a consistent pattern of responses was
produced. Lasix was used to simulate the decrease in plasma volume
observed during spaceflight. This dosage of lasix produced
approximately a 12% reduction in plasma volume from the euhydrated
level as has been reported previously (4). We randomized the order
of treatments to eliminate any effects of one LBNP test on a
subsequent test. All e_eriments begin at the same time Of day for
each individual subject to eliminate any circadian effects on our
findings. Testing began 2 hours after the ingestion of a small
meal. Lower body negative pressure was performed approximately 3
hours and 30 minutes after ingestion of fluids. At least 72 hours
was allowed between testing sessions.
Lower body negative pressure was applied using a chamber sealed
at the waist with a rubber gasket. A vacuum pump was then used to
withdraw air out of the chamber. The LBNP protocol is displayed in
Table i. The test was terminated if the subject's systolic blood
pressure dropped suddenly (greater than 25 mmHg in 1 minute),
systolic pressure reached 80 mmHg, bradycardia occurred (drop in
HR greater than 15 BPM), subject distress, or subject request.
Before, during, and immediately after LBNP a series of
physiological measures described below were determined every
minute. Only the results from the last 3 minutes from each stage
were analyzed as the first 2 minutes at each stage represent
transition responses.
Table i. LBNP protocol
Time at Stage (min) Pressure (mmHg)
20 0
5 -5
5 -i0
5 -20
5 -30
5 -40
5 -50
5 0
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Blood samples were taken from an antecubital vein before lasix
injection (baseline) after lasix injection, after drink ingestion,
2 and 1/2 hours after drink ingestion, 90 minutes before, and
immediately after LBNP. Changes in plasma volume were calculated
from hematocrit (microhematocrit technique) and hemoglobin (Coulter
Counter) ratios using the formula of Dill and Costill (5). A
direct measurement of plasma volume was performed once (human serum
labeled 125-I) in each subject before the first experimental
testing. This value was used as the absolute plasma volume and
changes were expressed relative to that value. Plasma osmolality
was determined using freezing point depression on all blood
samples. A 5 ml sample was required to do all of the hematological
analysis. Plasma levels of antidiuretic hormone, atrial
natriuretic factor, aldosterone, and catecholamines (epinephrine,
norepinephrine) were measured for certain blood samples.
Leg circumference measurements were made every minute with a
mercury-in-silastic strain gauge. The changes in leg circumference
during LBNP exposure were used to approximate the amount of venous
pooling in the legs.
Venous occlusion plethysmography with a mercury-in-silastic
strain gauge was used to measure forearm blood flow. The forearm
vasoconstrictor response as indicated by this technique was
measured at each step of LBNP. Heart rate was determined using a
three lead EKG. Blood pressure was measured once a minute using
a standard auscultatory technique. 2-D and M-Mode echocardiography
(ATL 4000 S/LC ultrasound system, ATL, Botheli, WA.) was performed
at each stage of LBNP in order to assess relative changes in left
ventricular dimensions with LBNP. Thoracic fluid index and stroke
volume were measured with bioelectrical impedance (BOMED).
Thoracic fluid index represents the impedance to current flow and
thus is inversely related to the amount of fluid in the chest.
EMG was used to assess abdominal and leg muscle tension in order
to monitor for muscle tensing. The subject was asked to maintain
a resting EMG level throughout all LBNP tests.
RESULTS
Plasma Volume and Plasma Osmolarity.
Plasma volume decreased by approximately 12% as a result of lasix
injection (Figure i). Drink ingestion with the isotonic drink
solution partially restored plasma volume to euhydrated levels.
Ingestion of the hypertonic drink solution (HYPER) fully restored
plasma volume to euhydrated levels. Plasma osmolarity did not
change through any of the dehydration or rehydration procedures
(Figure 2). This indicates the fluid losses and gains were
isotonic relative to the plasma. There was a slight increase in
plasma volume in all four conditions from the post drink to the pre
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LBNP sample. This was probably a result of a change in posture
(sitting to supine). During LBNP there was a decrease in plasma
volume in all four conditions. This hemoconcentration has been
commonly observed in the literature.
Thoracic Fluid Index.
Thoracic fluid index (TFI) increased in all four conditions with
increasing levels of LBNP (Figure 3). This represents an increase
in blood pooling in the legs and less in the thorax. The starting
TFI was also different between condition, reflecting the different
plasma volumes at the start of LBNP.
=
Heart Rate and Stroke Volume.
Heart rate increased in all conditions with increasing levels of
LBNP (Figure 4). Heart rates tended to be higher at the higher
levels of LBNP in the dehydrated condition than in the euhydrated,
isotonic, or hypertonic conditions. Stroke volume decreased with
increasing LBNP (Figure 5). Even though plasma volume and TFI were
different between the conditions, stroke volumes were similar in
the four conditions.
Blood Pressure.
Systolic blood pressure decreased with increasing levels of LBNP
(Figure 6). However, there were no differences in systolic blood
pressure between conditions. Diastolic pressure tended to increase
at the higher levels of LBNP in the dehydrated, isotonic, and
hyperhydrated conditions (Figure 7). There were no differences in
mean arteriai blood pressure with increasing LBNP stage or between
conditions.
Forearm Blood Flow and Leg Circumference.
Forearm blood flow decreased in all conditions with increasing
levels of LBNP (Figure 8). This was a reflex response to maintain
blood pressure in the face of falling venous return. There were no
differences between conditions. Leg circumference increased with
increasing levels of LBNP (Figure 9). As LBNP level increases,
venous pooling in the legs increase. There were no differences
in leg circumference with differing hydration states.
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DISCUSSION
Lasix reduced plasma volume by 12% in the present study. This
was similar to the reduction observed in our previous study (4).
Rehydration with an isotonic solution (present operational
countermeasure) partially restored plasma volume to the euhydrated
level. When subjects ingested the hypertonic solution, plasma
volume was fully restored to the euhydrated level. These data
support a recent study (2) which demonstrated that plasma volume
increased following ingestion of both an isotonic and hypertonic
drink solution, but the plasma volume was maintained longer with
the hypertonic solution.
Bungo and Charles (i) found that ingestion of a drink solution
improved orthostatic tolerance after spaceflight. They attributed
the decrease in orthostatic tolerance (higher heart rates, lower
blood pressures) to the decrease in plasma volume that has been
observed after space flight (8). We expected to see improved
orthostatic responses after rehydration with both the isotonic and
hypertonic drink solutions in comparison to the dehydrated
condition, our model for space flight. However, there were only
minor differences between conditions in heart rate, stroke
volume,blood pressure (systolic and diastolic), forearm blood flow,
and leg circumference.
It is possible that the differences in plasma volume produced in
this study were not great enough to produce marked differences in
cardiovascular responses. Other studies using exercise as a
stressor have shown that plasma volume differences of the magnitude
observed in this study produce significant differences in
cardiovascular responses (6).
It is also possible that the reduction in plasma volume produced
by lasix administration does not truly model spaceflight. Lasix
did produce a 12% reduction in plasma volume which is consistent
with space flight reductions in plasma volume. Our model might not
have produce some of the other physiological alterations that have
been observed with space flight. However, most of the alterations
that would influence orthostatic responses are thought to occur in
response to longer duration space flight (greater than 14 days).
Although a recent study by Convertino et al. (3) has demonstrated
changes in venous compliance with 4 days of 6 ° head down bed rest.
This reduction in venous compliance was inversely related to the
loss of the size of the leg muscle compartment. This might be a
contributing factor to the orthostatic intolerance that occurs
after short duration spaceflight and might be more important than
plasma volume alterations.
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Another explanation could be the difference in the composition of
the countermeasure. The present countermeasure consists of
ingesting 2 salt tablets and 8 ounces of water every 30 minutes
for 2 hours prior to reentry. In the present study, subjects
ingested a solution of .9% saline. Perhaps there are differences
in the physiological effects of ingesting a solution verses salt
tablets and water.
CONCLUSIONS
A hypertonic drink solution was more effective in restoring
plasma volume after dehydration than an isotonic solution. However,
there were no differences in their effects on an orthostatic
challenge. These data suggest that the plasma volume differences
produced in this study were not sufficient to produce differences
in the cardiovascular responses to an orthostatic challenge, or
there are other changes that occur during space flight that are
more important in determining orthostatic intolerance.
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Figure 1. Plasma volume plotted as a function of sample number. Mean + SE
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Figure 2. Plasma Osmolarity plotted as a function of sample number. Mean + SE
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Figure 3. Thoracic fluid index plotted as a function of LBNP stage. Mean + SE.
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Figure 4. Heart rate plotted as a function of LBNP stage• Mean + SE.
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Figure 5. Stroke volume plotted as a function of LBNP stage• Mean + SE.
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Figure 6. Systolic Blood Pressure plotted as a function of LBNP stage. Mean + SE.
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Figure 7. Diastolic blood presure plotted as a function of LBNP stage. Mean +SE.
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Figure 8. Forearm blood flow plotted as a function of LBNP stage. Mean + SE.
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Figure 9. Change in leg circumference plotted as a function of LBNP stage. Mean + SE.
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